Boston Scientific raises 2025 profit forecast on strong heart device sales
Boston Scientific raised its annual profit forecast after strong sales of its heart devices helped beat Wall Street expectations for first-quarter profit.
Boston Scientific (BSX) Stock Declines While Market Improves: Some Information for Investors
In the latest trading session, Boston Scientific (BSX) closed at $95.12, marking a -0.14% move from the previous day.
Should You Buy Boston Scientific Stock Ahead of Q1 Earnings?
Banking on robust above-market growth across all business units, BSX is expected to have witnessed strong international momentum in the first quarter.
Boston Scientific (BSX) Q1 Earnings Preview: What You Should Know Beyond the Headline Estimates
Beyond analysts' top -and-bottom-line estimates for Boston Scientific (BSX), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended March 2025.
Boston Scientific (BSX) Ascends But Remains Behind Market: Some Facts to Note
In the latest trading session, Boston Scientific (BSX) closed at $93.67, marking a +1.11% move from the previous day.
Boston Scientific (BSX) Is Considered a Good Investment by Brokers: Is That True?
When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often influence a stock's price, but are they really important?
Boston Scientific (BSX) Surges 6.8%: Is This an Indication of Further Gains?
Boston Scientific (BSX) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
Here's Why Boston Scientific (BSX) is a Strong Growth Stock
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
3 Stocks to Buy for "Liberation" From Trump Tariffs & Recession Woes
In 2025, companies like MASI, BSX and HIMS are expected to overcome challenges and sustain strong growth and market leadership.
Boston Scientific (BSX) Exceeds Market Returns: Some Facts to Consider
Boston Scientific (BSX) reachead $100.88 at the closing of the latest trading day, reflecting a +1.53% change compared to its last close.
International Expansion, Product Launches Support BSX Stock
Boston Scientific continues to successfully expand its operations across various geographies outside the United States.
Medical Products Leader Tops These Early-Bird Buy Points
Boston Scientific has the highest Composite Rating of 126 companies in the medical products industry. The post Medical Products Leader Tops These Early-Bird Buy Points appeared first on Investor's Business Daily.
